Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé Cboe Europe 14:18:41 20/08/2026			Varia. 5j.	Varia. 1 janv.
1 918,25 ^GBX	+0,12%		+3,26%	+5,07%

19/08	GSK plc : Deutsche Bank est neutre sur le titre	ZD
18/08	Roche: Chugai confie à GSK le développement d'un actif contre la dengue	AW

Autres langues

18/08	Chugai grants GSK exclusive global license for AID351 dengue antibody
17/08	FTSE 100 drifts lower as oil price pushes higher
17/08	European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
17/08	GSK Kept at Hold as Berenberg Notes Cost Savings Plan
17/08	Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech
14/08	FTSE 100 drifts lower in mixed day for Europe
14/08	FTSE 100 underwhelms in tepid end to week
14/08	WINNERS & LOSERS: Michael Page higher on UBS lift; software shares up
13/08	FTSE 100 down, peers rise as Fed hike bets cool
13/08	WINNERS & LOSERS: Anto cuts output view; BP, Shell, others ex-dividend
12/08	A No to BMS can open doors for a Yes to GSK
12/08	Trump's goal to split MMR vaccine could take a decade, experts say
12/08	WINNERS & LOSERS: Grocers down on drought worries; Balfour ups outlook
11/08	Global drugmakers invest billions to boost US presence
11/08	Trump streicht Empfehlungen für Kinderimpfungen zusammen
10/08	WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks
06/08	LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors
06/08	US FDA approves first mRNA flu shot from Moderna
04/08	Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says
04/08	ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
03/08	GSK India first-quarter profit rises on steady vaccine demand
03/08	RBC cuts JD Sports; Jefferies cuts Severn Trent
30/07	Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
30/07	GSK global supply chain director sells 38,000 shares
30/07	GSK, Relation Therapeutics to Collaborate on Human Cellular Perturbation Data